Pro Dex (PDEX) Research & Development (2010 - 2026)
Pro Dex (PDEX) posted Research & Development of $827000.0 for Q1 2026, up 12.67% sequentially from $734000.0 in Q4 2025, and down 12.67% YoY from $947000.0 in Q1 2025.
Pro Dex (PDEX) Research & Development (2010 - 2026) Analysis & Trends
Pro Dex has reported Research & Development for 14 years, with the latest figure at $827000.0 in Q1 2026.
- Quarterly Research & Development fell 12.67% year-over-year to $827000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.2 million (down 9.36% YoY) and the FY2025 annual result came in at $3.6 million, up 14.02% from the prior year.
- Research & Development rose to $827000.0 in Q1 2026 per PDEX's latest filing, from $734000.0 in the prior quarter.
- Over five years, Research & Development peaked at $947000.0 in Q1 2025 and troughed at $467000.0 in Q4 2022.
- A 5-year average of $784882.4 and a median of $788000.0 in 2023 frame the typical range for Research & Development.
- The sharpest annual moves came in 2022 and 2023: Research & Development tumbled 40.4% in 2022, then jumped 68.74% in 2023.
- Over 5 years, Research & Development stood at $467000.0 in 2022, then surged by 68.74% to $788000.0 in 2023, then gained by 19.54% to $942000.0 in 2024, then slipped by 22.08% to $734000.0 in 2025, then gained by 12.67% to $827000.0 in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $827000.0, $734000.0, and $768000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 370.60 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 258.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 663.00 Mn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 105.73 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 19.70 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 178.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 42.50 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 129.00 Mn |
| 10 | Pro Dex | 215.72 Mn | 204.74 Mn | 6.13 Mn | 827,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 827,000.00 |
| Dec 31, 2025 | 734,000.00 |
| Sep 30, 2025 | 768,000.00 |
| Jun 30, 2025 | 905,000.00 |
| Mar 31, 2025 | 947,000.00 |
| Dec 31, 2024 | 942,000.00 |
| Sep 30, 2024 | 843,000.00 |
| Jun 30, 2024 | 836,000.00 |
| Mar 31, 2024 | 760,000.00 |
| Dec 31, 2023 | 788,000.00 |
| Sep 30, 2023 | 805,000.00 |
| Jun 30, 2023 | 695,000.00 |
| Mar 31, 2023 | 713,000.00 |
| Dec 31, 2022 | 467,000.00 |
| Sep 30, 2022 | 929,000.00 |
| Jun 30, 2022 | 726,000.00 |
| Mar 31, 2022 | 658,000.00 |
| Dec 31, 2021 | 615,000.00 |
| Sep 30, 2021 | 980,000.00 |
| Jun 30, 2021 | 1.20 Mn |